overview of 2nd line treatment options in advanced hcc
Published 1 year ago • 1K plays • Length 14:53Download video MP4
Download video MP3
Similar videos
-
29:27
a new era in treating patients with advanced hcc: 2nd line treatment selection and when to switch?
-
4:27
advanced hcc: when to switch to 2nd line treatment - a patient case video
-
5:13
advanced hcc: treatment options for patients ineligible for io - patient case video
-
2:11
a new era in treating patients with advanced hcc
-
2:53
cor2ed the heart of medical education
-
15:12
panel discussion and summary treatment options for hcc patients
-
5:48
second-line therapy in advanced hcc
-
3:55
the use of immunotherapy in hcc – efficacy and safety
-
9:46
liver ultrasound normal vs abnormal image appearances comparison | liver pathologies usg
-
11:57
update from asco 2024
-
47:42
immune therapy in hepatocellular carcinoma
-
15:56
patients with advanced hcc not eligible for io in 1st line
-
1:04
dr franses on considerations for second-line treatment of hcc
-
4:21
the use of immunotherapy in hcc – in depth subgroup analyses and challenges
-
12:45
advanced gastric and gastroesophageal cancer in asia
-
24:30
reviewing the outcomes in hcc with 1st line immunotherapy: when is the right time to switch?
-
5:26
hcc whiteboard #1: the epidemiology of hepatocellular carcinoma and current standard of care
-
2:01
dr franses on the need for prospective data in second-line hcc and beyond
-
3:49
update from esmo 2024: immunotherapy (io) for hcc
-
4:32
overview and diagnosis of hcc
-
5:57
treatment options for locally advanced hcc
-
1:26:24
hepatocellular carcinoma: expert insights from the patient casebook